IBSA USA
Marcela Castano PharmD, BCPS, currently serves as a Medical Science Liaison at IBSA USA, focusing on endocrinology and pain since October 2023. Prior to this role, Marcela worked at Syneos Health as a Medical Science Liaison in the cardiovascular field from December 2022 to September 2023. Marcela's extensive experience includes positions as an Oncology Specialist and Clinical Pharmacist Specialist at JESSE BROWN VA MEDICAL CENTER from December 2017 to December 2022, a Clinical Pharmacist Specialist at Memorial Hospital Regional from July 2016 to June 2017, and a Clinical Pharmacist at Sinai Health System from October 2014 to June 2016. Marcela began professional training as a PGY-1 Pharmacy Resident at Cleveland Clinic from July 2013 to June 2014, after earning a Doctor of Pharmacy (Pharm.D.) degree from Nova Southeastern University in 2013.
This person is not in the org chart
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.